URB2 as an important marker for glioma prognosis and immunotherapy

Introduction: Glioma is the most common primary brain tumor and primary malignant tumor of the brain in clinical practice. Conventional treatment has not significantly altered the prognosis of patients with glioma. As research into immunotherapy continues, glioma immunotherapy has shown great potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chaoyou, Zhang, Zeyu, Han, Yongquan, Xu, Houshi, Zhu, Zhengyang, Du, Yichao, Hou, Pinpin, Yuan, Ling, Shao, Anwen, Zhang, Anke, Lou, Meiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080038/
https://www.ncbi.nlm.nih.gov/pubmed/37033651
http://dx.doi.org/10.3389/fphar.2023.1113182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080038/
https://www.ncbi.nlm.nih.gov/pubmed/37033651
http://dx.doi.org/10.3389/fphar.2023.1113182

Ejemplares similares